Figure 1 Study flow chart.

Slides:

Advertisements

Similar presentations

Figure 1 Alcohol consumption. A

Advertisements

Table 1 Patient characteristics of attendees of the influenza vaccination, irrespective of AF status From: Yield of screening for atrial fibrillation in.

Fig. 8 The two cases for the terminal edge e<sub>0</sub>

Figure 1 Proportion of criteria chosen (as percentages, grouped into issues). From: Developing national obesity policy in middle-income countries: a case.

Figure 2. Number of cases required in a Mendelian randomization analysis with a binary outcome and a single instrumental variable for 80% power with a.

J Exp Bot. 2017;68(17): doi: /jxb/erx352

Figure 2. Chronic kidney disease risk tool application.

Figure 1. Fertility and gender equity: three hypothetical dynamics according to the level of the Gender Gap over time. Note: the three scenarios differ.

Fig 1 The CONSORT participant flow diagram for primary endpoints.

Figure 3: MetaLIMS sample input.

Figure 5: Three-dimensional reconstruction of the CT scan showing the trapped air in the head and neck region. From: Distinct subcutaneous emphysema following.

Figure 2. The graphic integration of CNAs with altered expression genes in lung AD and SCC. The red lines represent the amplification regions for CNA and.

From: Learning by Working in Big Cities

Figure 1 Boxes represent effect estimates and lines represent 95% confidence intervals. (A) Effect of evolocumab on the risk of major vascular events [cardiovascular.

Fig. 1 Nodes in a conceptual knowledge graph

Figure 1: Pneumomediastinum and subcutaneous emphysema as indicated by the arrows. From: Pneumomediastinum and subcutaneous emphysema after successful.

From: Epidemiology of Inappropriate Empiric Antibiotic Therapy for Bacteremia Based on Discordant In vitro Susceptibilities: Risk factors and Taxon-level.

From: Magnetism and rotation in relativistic field theory

Figure 1: Newspaper sales October 2000–December 2010 (daily newspapers) through Audit Bureau of Calculations. Figures derived from

From: Detection of Bacteriuria by Canine Olfaction

Figure 1. The Vicsek set graphs $G_0$, $G_1$, $G_2$.

Figure 1 Relationship between creatine kinase-MB fraction elevation post-coronary artery bypass graft surgery with relative risk of mortality at 30 days.

Figure 2. Temperature-entropy diagram and the flow resistances of the power plant model of Figure 1. From: Thermodynamic optimization of a triple-shaft.

From: Introducing the PRIDE Archive RESTful web services

Figure 1 Overall analysis approach.

Notes: Household survey-based Gini and p90/p10 measures use the same definitions as employed by the UK’s official income distribution statistics (source:

Figure 1: Diagnostic performance of mortality prediction indices MPI4 (dash-dotted line), MPI5 (dashed line), and MPI6 (continuous line) for identification.

Figure 3: Full-body skeletal scintigraphy.

Figure 1. The flow chart illustrates the construction process of anti-CRISPRdb, and the information that users can obtain from anti-CRISPRdb. From: Anti-CRISPRdb:

Source:Zimnisky (2014). From: An Autopsy of Cooperation: Diamond Dealers and the Limits of Trust-Based Exchange Journal of Legal Analysis. Published online.

Figure 1. Percentage of infants with enzyme-linked immunosorbent assay antibody concentrations ≥0.1 IU/mL against diphtheria (day 127) and ≥0.35 μg/mL.

Abstract From: Lung transplantation after ex vivo lung perfusion in two Scandinavian centres Eur J Cardiothorac Surg. Published online October 29, 2018.

Figure 1. Evaluation the sensitivity and specificity value of urine LAM and sputum AFB Procedure using GeneXpert as the Reference (Gold Standard) From:

Serum Cholesterol levels mg/dl Frequency P

Figure 4 Change in plaque burden, plaque area, and plaque composition according to wall shear stress. (A and B) Change ... Figure 4 Change in plaque burden,

Figure 1. Overview of the workflow of NetworkAnalyst 3.0.

Figure 1 Hazard ratios as a function of annual mean PM2

All Psychosis Patients

FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.

Figure 2. Effect of gradually decreasing photoperiod on PHA response in Siberian hamsters. Asterisk (*) indicates statistical significance at P﹤0.05, determined.

Figure 1. Ratios of observed to expected numbers of exon boundaries aligning to boundaries of domain and disorder ... Figure 1. Ratios of observed to expected.

Figure 4. The mean of spermatocyte of various treatment groups

Fig. 1 Kaplan-Meier plot of cumulative incidence of cancer onset following dermatomyositis diagnosis stratified ... Anti-TIF1-Ab: anti-transcriptional.

Figure 1 The occurrence of maternal cardiovascular events for the different diagnosis groups. AOP, aortic pathology; ... Figure 1 The occurrence of maternal.

Characteristics LAM Result Total (%) 95% CI Odds ratio

Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.

FIGURE 1 Participant flow diagram. Exercise Counseling Clinic (ECC).

Figure 1. Mean concentration–time profiles of ascending doses of ivermectin in (a) PSAC and (b) SAC. Weight-dependent ... Figure 1. Mean concentration–time.

Figure 1 Nelson-Aalen estimates of the cumulative incidence rates for patients on versus off IST. ON = optic neuritis; ... Figure 1 Nelson-Aalen estimates.

FIGURE 1 Malta: a plate-style food guide

Figure 1. A, Crude incidence rates per 100 person-years of follow-up and 95% confidence intervals for each solid organ ... Figure 1. A, Crude incidence.

FIGURE 1 Study consort diagram

Figure 1 Study flowchart and patient flow

Land cover class in (Ha)

Figure 4. Classified landsat image 2016

Figure 1. Uncertainty reduction, value creation, and appropriation in two case studies. Unless provided in the caption above, the following copyright applies.

Figure 1 Ratio of the geometric mean concentration of hsTnT (A) and sST2 (B) at baseline (BL) and each subsequent ... Figure 1 Ratio of the geometric mean.

Land cover class in 2016 (%) Land cover class 2006 (Ha) l

Figure 1 Patient selection

Figure 1 Patient disposition

Figure 3. A basic scheme of a part of the cross-section of the experimental setup implemented for the measurements of asymmetric reduction of weight of.

Figure 1 Design of trials included in individual patient data meta-analysis. Unless provided in the caption above, the following copyright applies to the.

Figure 1 Distribution of WCD use days in WEARIT-II

Figure 1 Correlation between en face Oil-Red O staining and aortic root lesion size vs. plasma cholesterol and ... Figure 1 Correlation between en face.

Figure 1. Excess cost of methicillin-resistant Staphylococcus aureus (MRSA) compared with methicillin-susceptible S. ... Figure 1. Excess cost of methicillin-resistant.

Figure 1. Prevalence of parasitic infection and anemia among the children. Unless provided in the caption above, the following copyright applies to the.

Figure 1. GWAS Catalog associations for coronary artery disease plotted across all chromosomes. Associations added ... Figure 1. GWAS Catalog associations.

Figure 1 Mechanisms of mitral regurgitation.

Figure 1. Hepatitis C screening and diagnostic algorithm at the MSF clinic, Karachi, Pakistan, March 2016–September ... Figure 1. Hepatitis C screening.

Figure 1. Enteropathogen prevalence in stool samples collected from 996 children in the Sanitation Hygiene Infant ... Figure 1. Enteropathogen prevalence.

Presentation transcript:

Figure 1 Study flow chart. From: Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials Eur Heart J. 2017;38(22):1738-1746. doi:10.1093/eurheartj/ehx028 Eur Heart J | © The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Figure 2 Title: Left ventricular dysfunction without ischaemic heart disease: impact of primary prevention ICD on all-cause mortality. From: Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials Eur Heart J. 2017;38(22):1738-1746. doi:10.1093/eurheartj/ehx028 Eur Heart J | © The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Figure 3 (A) Title: Left ventricular dysfunction with ischaemic heart disease: impact of primary prevention ICD on all-cause mortality. (B). Title: Left ventricular dysfunction with ischaemic heart disease: impact of primary prevention ICD implanted during a dedicated procedure on all-cause mortality. From: Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials Eur Heart J. 2017;38(22):1738-1746. doi:10.1093/eurheartj/ehx028 Eur Heart J | © The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Figure 4 Left ventricular dysfunction with acute myocardial infarction: impact of primary prevention ICD on all-cause mortality. From: Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials Eur Heart J. 2017;38(22):1738-1746. doi:10.1093/eurheartj/ehx028 Eur Heart J | © The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.